{"id":"https://openalex.org/W4416670710","doi":"https://doi.org/10.1158/1078-0432.30709195","title":"Supplementary Fig. 4 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell\u2013intrinsic Amplification of Type I IFN Signaling","display_name":"Supplementary Fig. 4 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell\u2013intrinsic Amplification of Type I IFN Signaling","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416670710","doi":"https://doi.org/10.1158/1078-0432.30709195"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30709195","doi":"https://doi.org/10.1158/1078-0432.30709195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Fig_4_from_MEK_Inhibition_Sensitizes_Pancreatic_Cancer_to_STING_Agonism_by_Tumor_Cell_intrinsic_Amplification_of_Type_I_IFN_Signaling/30709195/1/files/59834011.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4416670710"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Fig_4_from_MEK_Inhibition_Sensitizes_Pancreatic_Cancer_to_STING_Agonism_by_Tumor_Cell_intrinsic_Amplification_of_Type_I_IFN_Signaling/30709195/1/files/59834011.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036481001","display_name":"Razmik Ghukasyan","orcid":"https://orcid.org/0000-0003-1795-1892","observed_orcids":["https://orcid.org/0000-0003-1795-1892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Razmik Ghukasyan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1795-1892","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038792983","display_name":"Keke Liang","orcid":"https://orcid.org/0000-0002-0007-6326","observed_orcids":["https://orcid.org/0000-0002-0007-6326","https://orcid.org/0009-0001-5799-0231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keke Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0007-6326","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063951168","display_name":"Kevin Chau","orcid":"https://orcid.org/0000-0001-9945-9169","observed_orcids":["https://orcid.org/0000-0001-9945-9169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Chau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9945-9169","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043782637","display_name":"Luyi Li","orcid":"https://orcid.org/0000-0001-6096-6403","observed_orcids":["https://orcid.org/0000-0001-6096-6403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luyi Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6096-6403","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009235216","display_name":"Charlotte Chan","orcid":"https://orcid.org/0000-0001-5036-7298","observed_orcids":["https://orcid.org/0000-0001-5036-7298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charlotte Chan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5036-7298","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066633792","display_name":"Evan R. Abt","orcid":"https://orcid.org/0000-0002-3160-7134","observed_orcids":["https://orcid.org/0000-0002-3160-7134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan R. Abt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3160-7134","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001373227","display_name":"Thuc M. Le","orcid":"https://orcid.org/0000-0003-2364-9374","observed_orcids":["https://orcid.org/0000-0003-2364-9374"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thuc Le","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2364-9374","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086695712","display_name":"Joon Y. Park","orcid":"https://orcid.org/0000-0002-3847-9198","observed_orcids":["https://orcid.org/0000-0002-3847-9198"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joon Y. Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3847-9198","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029117087","display_name":"Nanping Wu","orcid":"https://orcid.org/0000-0001-6415-009X","observed_orcids":["https://orcid.org/0000-0001-6415-009X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nanping Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6415-009X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008210852","display_name":"Alykhan Premji","orcid":"https://orcid.org/0000-0002-0326-3717","observed_orcids":["https://orcid.org/0000-0002-0326-3717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alykhan Premji","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0326-3717","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045676945","display_name":"Robert D. Damoiseaux","orcid":"https://orcid.org/0000-0002-7611-7534","observed_orcids":["https://orcid.org/0000-0002-7611-7534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Damoiseaux","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7611-7534","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042715452","display_name":"Tony Luu","orcid":"https://orcid.org/0009-0003-1014-9300","observed_orcids":["https://orcid.org/0009-0003-1014-9300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tony Luu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-1014-9300","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053487389","display_name":"Amanda N. Labora","orcid":"https://orcid.org/0000-0001-6273-0939","observed_orcids":["https://orcid.org/0000-0001-6273-0939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Labora","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6273-0939","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032597456","display_name":"Khalid Rashid","orcid":"https://orcid.org/0000-0002-5070-8010","observed_orcids":["https://orcid.org/0000-0002-5070-8010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khalid Rashid","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5070-8010","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030632046","display_name":"Jason M. Link","orcid":"https://orcid.org/0000-0002-6892-0431","observed_orcids":["https://orcid.org/0000-0002-6892-0431"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason M. Link","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6892-0431","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018755772","display_name":"Caius G. Radu","orcid":"https://orcid.org/0000-0002-9338-5397","observed_orcids":["https://orcid.org/0000-0002-9338-5397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caius G. Radu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9338-5397","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058851560","display_name":"Timothy R. Donahue","orcid":"https://orcid.org/0000-0002-1175-2545","observed_orcids":["https://orcid.org/0000-0002-1175-2545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy R. Donahue","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1175-2545","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.3799000084400177,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/type-i-interferon-signaling","display_name":"type I interferon signaling","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ifnar1","display_name":"IFNAR1","score":0.6650000214576721},{"id":"https://openalex.org/keywords/diabzi","display_name":"diABZI","score":0.8999999761581421},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cfpac-1-cells","display_name":"CFPAC-1 cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/tumor-cell-intrinsic-signaling","display_name":"tumor cell-intrinsic signaling","score":0.6430000066757202},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.6647999882698059},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.605400025844574},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5949000120162964},{"id":"https://openalex.org/C2779300339","wikidata":"https://www.wikidata.org/wiki/Q7617409","display_name":"Sting","level":2,"score":0.583299994468689},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5238999724388123},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.445499986410141},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.43470001220703125},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.41620001196861267},{"id":"https://openalex.org/C2777349159","wikidata":"https://www.wikidata.org/wiki/Q18055374","display_name":"Stimulator of interferon genes","level":4,"score":0.3749000132083893},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.3513000011444092},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.3140000104904175},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31310001015663147},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3070000112056732},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.298799991607666},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2842999994754791},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C14527384","wikidata":"https://www.wikidata.org/wiki/Q4693403","display_name":"Agonism","level":3,"score":0.25690001249313354},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2529999911785126}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709195","doi":"https://doi.org/10.1158/1078-0432.30709195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Fig_4_from_MEK_Inhibition_Sensitizes_Pancreatic_Cancer_to_STING_Agonism_by_Tumor_Cell_intrinsic_Amplification_of_Type_I_IFN_Signaling/30709195/1/files/59834011.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709195","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Fig_4_from_MEK_Inhibition_Sensitizes_Pancreatic_Cancer_to_STING_Agonism_by_Tumor_Cell_intrinsic_Amplification_of_Type_I_IFN_Signaling/30709195","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709195","doi":"https://doi.org/10.1158/1078-0432.30709195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Fig_4_from_MEK_Inhibition_Sensitizes_Pancreatic_Cancer_to_STING_Agonism_by_Tumor_Cell_intrinsic_Amplification_of_Type_I_IFN_Signaling/30709195/1/files/59834011.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416670710.pdf","grobid_xml":"https://content.openalex.org/works/W4416670710.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376872402","https://openalex.org/W4385836420","https://openalex.org/W4402798244","https://openalex.org/W4411967490","https://openalex.org/W4400957699","https://openalex.org/W4387952213","https://openalex.org/W3127873789","https://openalex.org/W3213222536","https://openalex.org/W3190260612","https://openalex.org/W3046354124"],"abstract_inverted_index":{"Supplementary":[0],"Fig.":[1],"4":[2],"Immunoblot":[3,29],"analysis":[4,30,51],"demonstrating":[5],"the":[6,53],"effect":[7],"of":[8,31,52,55],"\u00b1":[9,39,43,56,61],"100":[10,44,57],"U/ml":[11,58],"exogenous":[12,59],"IFN":[13,60],"on":[14],"CFPAC-1":[15,32],"and":[16,34],"SUIT2":[17],"parental":[18,33],"cells":[19,36],"compared":[20],"to":[21,38],"their":[22],"respective":[23],"IFNAR-deficient":[24],"isogenic":[25],"cell":[26],"lines.":[27],"(B)":[28],"IFNAR1-KO":[35],"exposed":[37],"1":[40,62],"\u00b5M":[41,63],"diABZI":[42,64],"nM":[45],"trametinib":[46],"for":[47,65],"24":[48,66],"h":[49],"(C)Immunoblot":[50],"effects":[54],"h.":[67]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416670710","counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}
